IM Cannabis Corp. Files Routine 6-K Report

Ticker: IMCC · Form: 6-K · Filed: 2025-03-20T00:00:00.000Z

Sentiment: neutral

Topics: reporting, sec-filing, foreign-private-issuer

TL;DR

IM Cannabis Corp. filed a standard 6-K, no major news.

AI Summary

IM Cannabis Corp. filed a Form 6-K on March 20, 2025, reporting for the month of March 2025. The company, incorporated in Israel with its principal executive offices at Kibbutz Glil Yam, is a foreign private issuer and files annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.

Why It Matters

This filing indicates IM Cannabis Corp. is fulfilling its regular reporting obligations as a foreign private issuer with the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information or financial disclosures.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically to provide information that the issuer makes or is required to make public in its home country.

What is IM Cannabis Corp.'s SEC file number?

IM Cannabis Corp.'s SEC file number is 001-40065.

Where are IM Cannabis Corp.'s principal executive offices located?

IM Cannabis Corp.'s principal executive offices are located at Kibbutz Glil Yam, Central District, Israel.

Does IM Cannabis Corp. file annual reports under Form 20-F or 40-F?

IM Cannabis Corp. files annual reports under Form 20-F.

What period does this Form 6-K report cover?

This Form 6-K reports for the month of March 2025.

From the Filing

0001178913-25-000951.txt : 20250320 0001178913-25-000951.hdr.sgml : 20250320 20250320071502 ACCESSION NUMBER: 0001178913-25-000951 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250320 FILED AS OF DATE: 20250320 DATE AS OF CHANGE: 20250320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25754482 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2532875.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of March 2025 .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.     SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       IM CANNABIS CORP.     (Registrant)         Date: March 20, 2025 By: /s/ Oren Shuster     Name:      Oren Shuster     Title: Chief Executive Officer and Director EXHIBIT INDEX   99.1 News Release dated March 20, 2025 EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET   TORONTO and GLIL YAM, Israel, March 20, 2025/CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the " Company ", " IMCannabis ", or " IMC "), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens.   The Company will host a zoom web conference on the same day at 9:00a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here . All relevant

View on Read The Filing